A proposal to allow medical marijuana in Alabama was approved by the Senate Judiciary Committee on Wednesday morning.
Senate Bill 46, called the Compassion Act, was proposed by Republican State Sen. Tim Melson of Florence. It passed by a vote of 8-3. The bill will now go to the senate floor.
The proposal calls for establishing an 11-member Alabama Medical Cannabis Commission to license growers, oversee cultivation, implement regulations and oversee dispensing of medical marijuana to patients who qualify for a medical cannabis card.
Melson’s bill won approval by the senate last year but died when the legislature shut down early due to COVID-19.
This year’s bill is the same, along with amendments added on the Senate floor last year.
“It’s encouraging to see lawmakers making progress towards legalizing medical marijuana in Alabama,” Karen O’Keefe, state policies director for the Marijuana Policy Project, told Marijuana Moment, which is tracking the bill. “It is morally wrong to continue to treat Alabamians who suffer from serious medical conditions as criminals for using a substance that is now legal in 36 states. However, we urge lawmakers to revise the provisions of the bill that create significant barriers for patients and their physicians.” [Read More @ Alabama.com]
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
POSaBIT, the cannabis point-of-sale (POS) and payments software company, this morning announced its planned acquisition of MJ Platform (MJ Freeway), Leaf Data Systems, and Ample Organics from embattled software company…
New York marijuana regulators on Wednesday approved dozens of conditional adult-use dispensary licenses in a session during which members also discussed adopting bylaws for how the board runs meetings and makes decisions.…
By Griffin Thorne, Attorney at Harris Bricken Since the passage of the 2018 Farm Bill, the hemp CBD industry has been eagerly awaiting FDA CBD regulations. In that time, FDA…
The US Food and Drug Administration has finalized a 2020 draft guidance outlining how sponsors and investigators can conduct clinical trials for certain drugs containing cannabis or cannabis-derived compounds without…